ANI Pharmaceuticals | ANIP - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
AbbVie USD 41.64B 458M 2026-06
ANI Pharmaceuticals USD 283.65M 44.14M 2026-06
Aurora Cannabis CAD 66.93M 79M 2026-03
Canopy Growth CAD 158.44M 60.15M 2026-03
Eli Lilly USD 47.74B 11.11B 2026-06
Emergent BioSolutions USD 651.3M 12.7M 2023-12
Heron Therapeutics USD 92.14M 1.63M 2026-06
Hikma Pharmaceutical USD 1.45B 603M 2025-12
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Nektar Therapeutics USD 57.71M 4.17M 2026-03
Novartis USD 31.37B 4.1B 2026-03
Omeros USD 85.5M 2.28M 2025-06
Perrigo USD 1.05B 57.2M 2026-06
Sun Pharmaceuticals INR 226.22B 7.93B 2026-03
Teva Pharmaceutical Industries USD 15.65B 2.11B 2026-06